Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Rezolve Ai, a global leader in AI-powered commerce technology, announced that its CEO will participate in the H.C. Wainwright 28th Annual Global Investment Conference and that the company will host an Investor Day at Nasdaq MarketSite. These events will highlight Rezolve Ai's expanding AI infrastructure and agentic commerce business, providing inve…
Senseonics Holdings, Inc., a US-based medical technology company specializing in implantable continuous glucose monitoring systems for diabetes, announced participation in two upcoming institutional investor conferences. Management will engage with investors through meetings and presentations, highlighting their Eversense CGM product line, which of…
Circle8 Group, Inc. announced it has submitted a proposal to acquire SThree plc, a UK-based specialist STEM business, aiming to significantly increase its global scale and establish a leading international IT and technology platform. The transaction is structured to avoid dilution of existing shareholders and combines their complementary strengths,…
SCYNEXIS, a clinical-stage biotechnology company focused on severe rare diseases, appointed Sanjay Subramanian as Chief Financial Officer, effective September 9, 2026. He brings over 20 years of financial and operational experience in biotech and pharma, including previous CFO roles and expertise in capital markets and business development. The com…
SEALSQ (NASDAQ: LAES) and BWT Alpine Formula One Team have advanced their collaboration by integrating ColibriTD's hybrid quantum-classical simulation technology to accelerate and improve fundamental physics problem-solving within Formula One engineering. This project aims to leverage quantum-powered computations alongside quantum-secure infrastruc…
Rhythm Pharmaceuticals announced new data presentations at the European Society for Paediatric Endocrinology meeting highlighting real-world and Phase 3 clinical trial results for setmelanotide in treating pediatric acquired hypothalamic obesity. The data demonstrate significant and sustained BMI reductions and improvements across several cardiomet…
electroCore, Inc., a commercial-stage bioelectronic medicine company, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference where its Co-CEO will engage with investors. The company focuses on non-invasive bioelectronic therapies for chronic pain and wellness through products like gammaCore and Quell.
Erasca, Inc. announced upcoming presentations at the 38th EORTC-NCI-AACR Symposium, including updated clinical data for ERAS-0015 from the Phase 1 AURORAS-1 trial and nonclinical combination data of ERAS-0015 and ERAS-4001 showing synergistic effects. These advancements highlight Erasca's progress in developing innovative therapies targeting RAS-mu…
Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced completed measures between January 2025 and June 2026 that reduced its annualized cash operating costs by about $1.71 million. Significant savings stemmed from technology-driven automation, workforce restructuring, and cost reductions in insurance and infrastruct…
Humacyte, a Nasdaq-listed biotechnology company specializing in bioengineered human tissues, announced participation in the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will showcase its FDA-approved acellular tissue engineered vessel (ATEV) technology and ongoing clinical trials targeting vascular and other medical ap…
Evolution Metals & Technologies Corp. (EM&T), a U.S.-based critical materials and advanced manufacturing company, provided initial revenue guidance projecting a significant jump from $5-$8 million in fiscal 2026 to $400-$460 million in fiscal 2027. This growth is driven by a major capacity expansion at their Pohang, South Korea facility, boosting r…
Ionic Digital Inc. announced that ERCOT has provisionally classified the company's final 466 MW energization request at its Ward County campus as Base Load in the Batch Zero process, moving the campus closer to its full planned 700 MW capacity. The company targets completing this energization by the end of 2027. This classification is provisional a…
WTW, a global advisory and solutions company, announced a strategic partnership with enterprise AI platform Lyzr to help organizations implement AI-driven workforce transformation, combining WTW's consulting expertise with Lyzr’s agentic AI to move clients from strategy to operational execution and business impact.
Legend Biotech announced that updated long-term follow-up and real-world evidence from its CARVYKTI® (ciltacabtagene autoleucel) clinical trials, including CARTITUDE-2 Cohort A, will be presented at the 23rd International Myeloma Society Annual Meeting. These new data further support CARVYKTI's safety and efficacy in treating relapsed/refractory mu…
Syntec Optics announced a more than doubling of purchase orders to over $9 million, driven by increased demand for optics used in missile guidance, night vision, targeting lasers, and AR/mixed reality headsets for soldiers. This growth reflects heightened defense spending and global geopolitical tensions, positioning Syntec as a key supplier of hig…
Fusion Fuel Green PLC's subsidiary Al Shola Gas has added a new LPG bobtail tanker in Dubai expected to generate approximately $1.6 million annual recurring revenue at target delivery volumes. The new tanker increases the fleet to 53 vehicles, improving delivery reliability and reducing third-party reliance. A smaller bobtail is also on order to se…
TTM Technologies announced a proposed private offering of $500 million in senior notes due 2034, alongside incremental senior secured term loans totaling $1.1 billion. The proceeds aim to fund the acquisition of Epiq Solutions, support general corporate purposes, and potentially reduce borrowings under its revolving credit facility. The notes offer…
CAMP4 Therapeutics Corporation has received regulatory authorization from the UK's MHRA to include UK sites in its global Phase 1/2 clinical trial of CMP-002, a potential disease-modifying antisense oligonucleotide treatment for SYNGAP1-related disorder. This follows recent clearances in Australia and Argentina, with the company on track to start t…
SKYX Platforms Corp. announced a merger with Deako Inc., a leading U.S. AI smart home and intelligent lighting company backed by Silicon Valley investors. This merger aims to combine SKYX's safe, plug & play AI platform with Deako's smart wall switch technologies, creating a comprehensive smart home solution for builders, hotels, and professional m…
CervoMed announced that initial biomarker results from its Phase 2a clinical trial of neflamapimod in nonfluent variant primary progressive aphasia (nfvPPA) will be presented as a late-breaking oral session at the ISFTD 2026 meeting. The trial completed enrollment with 25 participants and evaluates safety and clinical effects of neflamapimod, a dru…
Immuneering Corporation announced that it will present new analyses at the AACR Conference demonstrating that their drug candidate, atebimetinib, exhibits a dual mechanism by both reducing tumor volume and preserving body mass in pancreatic cancer patients, potentially extending overall survival. The findings build on previous data showing 84% of t…
TG Therapeutics, a commercial-stage biotech company focused on treatments for B-cell diseases, announced that its CEO, Michael S. Weiss, will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The company highlighted its FDA-approved multiple sclerosis treatment, BRIUMVI®, and will webcast the CEO's fireside chat during th…
Helus Pharma announced that its CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The company is focused on developing novel serotonergic agonists (NSAs) aimed at treating mental health conditions such as depression and anxiety, with two lead drug candidates in advanced clinical…
Copa Holdings announced a preliminary increase in passenger traffic statistics for August 2026, showing a 16.8% rise in both available seat miles (ASM) and revenue passenger miles (RPM) compared to August 2025. The load factor remained steady at 88.3%, indicating efficient capacity utilization despite increased capacity.
Burning Rock Biotech Limited reported its second quarter 2026 financial results, showing a 9.3% year-over-year decrease in total revenue to RMB134.7 million (US$19.9 million), driven by reduced pharma R&D services and central laboratory testing offset partially by growth in in-hospital sales. The company progressed in regulatory review for several …
